RA

Rakesh Agarwal

Active Director Director DIN 00840177
DIN 00840177 First appointment Mar 2005 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2005
Shareholding value •••• Premium profile

About Rakesh Agarwal

Data last updated:

Rakesh Agarwal is a Director at Emdon Pharmaceuticals Private Limited (since 2005). The company operates in Chemicals. Emdon Pharmaceuticals Private Limited reported revenue of ₹22 Lakh (FY 2017).

DIN 00840177
Primary Designation Director
Industry Chemicals
First Appointment 07 Mar 2005
Oldest Company Age 21 yrs
Largest company Emdon Pharmaceuticals Private Limited · ₹22 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Mar 20052005₹22 Lakh (FY 2017)Active

Board colleagues of Rakesh Agarwal

NameDINCompanyDesignation
Pradeep Kumar Agarwal00852052Emdon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Emdon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Agarwal

Rakesh Agarwal currently holds 1 directorship: Emdon Pharmaceuticals Private Limited (Director, since 07 Mar 2005, revenue ₹22 Lakh (FY 2017)).

Rakesh Agarwal was first appointed on 07 Mar 2005 as Director at Emdon Pharmaceuticals Private Limited.

The current boards of Rakesh Agarwal's companies include Pradeep Kumar Agarwal (Emdon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available